Cartigenix HP® Backed by Three Human Studies as Clinicians Seek Evidence-Based Joint Health Options

For decades, supplement research has not supported cartilage regeneration. A randomized, placebo-controlled study in Pharmaceutical Research documented measurable cartilage regeneration biomarkers at 90 days, a breakthrough for the category* (Vaidya 2025) Three published human studies covering more than 1,700 participants anchor the Cartigenix HP® research profile In the studies, participants showed an average 67% reduction in pain scores and an average 50% increase in walking distance within 90 days, with noticeable improvements as early as 15 days SCOTTSDALE, AZ, May 22, 2026 (GLOBE NEWSWIRE) -- Cartilage regeneration has long been unsupported in peer-reviewed supplement literature, a ceiling reflected in decades of clinical research on the category's dominant ingredients, glucosamine and chondroitin.